B- or T-lymphocyte-mediated autoimmune disorders may lead to clinical disease characterized by low blood cell counts. The term autoimmune cytopenias has been collectively applied to this heterogeneous group of disorders. After the introduction of the humanized, chimeric monoclonal anti-CD20 antibody
No takes yet. Share an insight, caveat, or question.
Sigbjørn Berentsen (2007) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: